Patient consult

PATIENT

Age Sex Weight kg

Pregnancy

Trimester

Breastfeeding

DISEASE

Severity

Hospitalized / inpatient IV steroid non-response (day 3+, Oxford)

Phase

Extent (Montreal) Mayo score (0-12)

Location Behavior CDAI Perianal disease

CRP mg/L Calpro µg/g Alb g/dL Hb g/dL

TREATMENT HISTORY

Failed drug classes

Specific prior biologics / small molecules

Steroid-dependent

SAFETY SCREEN

TB status

LTBI treatment

HBV status C. difficile Cardiovascular risk

Patient consents to processing of genetic data (GDPR Art. 9) — without consent, TPMT/NUDT15 results are not sent to the engine

RENAL & HEPATIC

eGFR mL/min/1.73m² {{ f_egfr }}

JAK, MTX, cyclosporine and 5-ASA require eGFR ≥30

Child-Pugh

On dialysis

SEROLOGY & CONTEXT

VZV status CMV Smoking Disease duration (y)

Extraintestinal manifestations

CARDIAC

CHF (NYHA)

MI within 6 months AV block II/III Functional pacemaker Severe sleep apnea

VIRAL & GENETICS

Hepatitis C

HCV treatment

HIV

CD4 /µL

EBV status TPMT status

NUDT15 deficiency

MALIGNANCY · SURGERY · TDM

Years since malignancy Corticosteroid status

Prior IBD surgery

Weeks since surgery

Toxic megacolon

Pouchitis (post-IPAA)

TDM · current biologic

Trough µg/mL Anti-drug antibodies

PATIENT PREFERENCES

Preferred route

Needs fast onset Injection aversion

MCDA WEIGHTS

Σ {{ weightSum }}%

LIVE RECAP

SAVED CASES

{{ s.when }}

Clinical decision support for licensed physicians — does not replace clinical judgment. Demo build; no PHI stored.

ENGINE OUTPUT

          
          {{ engineStatus }}
        

✓ {{ passedLabel }}

! {{ w.code }}

SAFETY-GATED THERAPIES

C. DIFFICILE — TREAT FIRST Initiate before or concurrently with IBD therapy — not after it

ECCO Infections 2026 Statement 22 · IDSA 2021 · DGVS 2025

ASUC RESCUE MODE {{ rescuePhaseLabel }}

ACG 2025 · AGA Inpatient 2025 · ECCO 2024 §4.5 · BSG 2025 §3.5 · DGVS 2025 §5.21

{{ s.name }} {{ s.cls }} · {{ s.dose }}

                SCENARIOTOP THERAPYTOP-3
              

{{ w.name }} {{ w.top }} changed {{ w.shift }}

Providing these fields would make recommendations more precise.

{{ c.v }}

MCDA dimensions renormalized 0–100 against the best in batch — same convention as the composite score.

{{ r.rank }}

AGA {{ r.tier }}

EL {{ r.el }}

{{ r.dose }} · {{ r.route }}

GKV {{ r.costLine }}

{{ r.scoreLine }}

⚠{{ r.flagText }}

{{ r.score }}

{{ metaLine }}
Rankings: live engine output — this page calls the same pipeline as POST /v1/recommendation. Digital-twin curves and what-if sensitivity are client-side estimates on the engine's data tables. Prices: GKV Lauer-Taxe 2025 (EUR).

⌁ Describe the patient and run the engine — therapies are gated, scored and ranked with citations.

Therapy catalog

{{ dSub }}

{{ s.h }}

Outcome simulator

No active case. Run a consult first — its top therapies feed the simulator. Run a consult

{{ caseLine }}

PROJECTED CLINICAL REMISSION — 52 WEEKS

RCT-anchored · induction + maintenance rates

{{ t.ind }}%
induction remission

{{ t.maint }}%
remission w52

{{ t.resp }}%
clinical response

{{ t.onset }}w
onset

{{ t.cost }} €/yr GKV {{ t.cpr }} €/remission

Induction {{ t.indCost }}

Biosimilar {{ t.bio }}

{{ t.costSrc }}

{{ t.ae }}

Explainability

No active case. The narrative explains the latest consult's ranking. Run a consult

{{ caseLine }}

CLINICAL NARRATIVE

MCDA DIMENSION BREAKDOWN — TOP 3

Prior authorization

No active case. Prior-auth documentation is generated from a consult. Run a consult

Requesting:

CLINICAL JUSTIFICATION LETTER

{{ authLetter }}

Guideline concordance

Do the rankings agree with the guidelines?

For the current case, each ranked therapy is checked against the indexed adult societies (ECCO, ACG, AGA, DGVS, BSG). Concordance = the share of recommending societies behind each pick.

No active case. Concordance is computed on the latest consult's ranking. Run a consult

{{ caseLine }}

{{ ccTop3Pct }}

Top-3 guideline-concordant

Engine #1 pick

{{ ccAvg }}

Avg societies / therapy

{{ r.rank }}

{{ r.pct }}

of 5 indexed

Endorsement = the society's guideline corpus indexes this therapy. ESPGHAN/NASPGHAN (pediatric) and PIANO (pregnancy registry) are out of scope for adult cases.

Clinician validation

{{ caseLine }}

Do you agree with the engine's #1 recommendation?

FEEDBACK LOG

No feedback recorded yet in this browser.

Cohort analytics

Aggregated over consults run in this browser — no PHI leaves the device.

{{ s.value }}

TOP-RANKED THERAPY DISTRIBUTION

Run consults to populate cohort analytics.

{{ infoEyebrow }}

Settings

Language

EN · DE

Local data

About this build

{{ buildInfo }}